Radical approach to diabetic nephropathy.

Area of Science:

• Nephrology
• Endocrinology
• Oxidative Stress Research

Background:

• Diabetic complications, particularly chronic kidney disease (CKD), are linked to increased reactive oxygen species (ROS) and oxidative stress.
• High glucose levels in diabetes promote the upregulation of transforming growth factor-beta1 (TGF-beta1) and angiotensin II (Ang II) in renal cells.
• These factors (high glucose, TGF-beta1, Ang II) generate and signal through ROS, mediating cellular damage.

Purpose of the Study:

• To review the role of ROS in the pathogenesis of diabetic nephropathy.
• To explore the potential of antioxidant strategies and pathway inhibitors in preventing or delaying diabetic kidney disease.

Main Methods:

• Literature review of studies investigating ROS, oxidative stress, and diabetic complications.
• Analysis of mechanisms by which high glucose, TGF-beta1, and Ang II induce ROS production and signaling.
• Evaluation of the efficacy of interventions like glycemic control, Ang II inhibition, antioxidants, transketolase activators, and PARP inhibitors.

Main Results:

• High glucose, TGF-beta1, and Ang II stimulate ROS production and signaling in renal cells, activating pathways like protein kinase C and nuclear factor-kappaB.
• Glycemic control and Ang II inhibition demonstrate antioxidant effects, delaying diabetic nephropathy onset and progression.
• Various antioxidants, transketolase activators, and poly (ADP-ribose) polymerase inhibitors have shown promise in preventing or mitigating hyperglycemic damage.

Conclusions:

• Targeting ROS overproduction and blocking ROS-induced pathways is crucial for managing diabetic kidney disease.
• A combination of strategies—reducing ROS generation, enhancing ROS removal, and inhibiting ROS-mediated signaling—may effectively prevent and treat CKD in diabetic patients.